The content is available as a PDF (50.4 KB).
. 2002 Jun 7;15(1-3):159–165. doi: 10.1155/1999/748254
Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe
P J Morrison
1,*, C M Steel
2, H F A Vasen
3, D Eccles
4, D G R Evans
5, P Møller
6, S Hodgson
7, D Stoppa-Lyonnet
8, J Chang-Claude
9, M Caligo
10, E Olah
11, N E Haites
12, N C Nevin
1
P J Morrison
1Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast, BT9 7AB, UK
Find articles by P J Morrison
C M Steel
2School of Biomedical Sciences, University of St. Andrews, Scotland, UK
Find articles by C M Steel
H F A Vasen
3Foundation for the Detection of Hereditary Tumours, c/o University Hospital, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands
Find articles by H F A Vasen
D Eccles
4Department of Human Genetics, Princess Ann Hospital, Southampton SO16 5YA, UK
Find articles by D Eccles
D G R Evans
5Department of Medical Genetics, St Mary’s Hospital, Manchester, UK
Find articles by D G R Evans
P Møller
6Unit of Medical Genetics, The Norwegian Radium Hospital, N-0310 Oslo, Norway
Find articles by P Møller
S Hodgson
7Division of Medical and Molecular Genetics, Guy’s Hospital, London Bridge, London SE1 9RT, UK
Find articles by S Hodgson
D Stoppa-Lyonnet
8Unité de Génétique Oncologique Institut Curie - Section Médicale 26, rue d’Ulm 75231 Paris Cedex 05, France
Find articles by D Stoppa-Lyonnet
J Chang-Claude
9Division of Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Find articles by J Chang-Claude
M Caligo
10Institute of Pathology, University of Pisa, via Roma, 57, 56126 Pisa, Italy
Find articles by M Caligo
E Olah
11Department of Molecular Biology, National Institute of Oncology, H-1525 Budapest, Hungary
Find articles by E Olah
N E Haites
12Department of Medicine and Therapeutics (Medical Genetics), University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
Find articles by N E Haites
N C Nevin
1Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast, BT9 7AB, UK
Find articles by N C Nevin
1Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast, BT9 7AB, UK
2School of Biomedical Sciences, University of St. Andrews, Scotland, UK
3Foundation for the Detection of Hereditary Tumours, c/o University Hospital, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands
4Department of Human Genetics, Princess Ann Hospital, Southampton SO16 5YA, UK
5Department of Medical Genetics, St Mary’s Hospital, Manchester, UK
6Unit of Medical Genetics, The Norwegian Radium Hospital, N-0310 Oslo, Norway
7Division of Medical and Molecular Genetics, Guy’s Hospital, London Bridge, London SE1 9RT, UK
8Unité de Génétique Oncologique Institut Curie - Section Médicale 26, rue d’Ulm 75231 Paris Cedex 05, France
9Division of Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
10Institute of Pathology, University of Pisa, via Roma, 57, 56126 Pisa, Italy
11Department of Molecular Biology, National Institute of Oncology, H-1525 Budapest, Hungary
12Department of Medicine and Therapeutics (Medical Genetics), University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
✉
*P. J. Morrison: p.morrison@cableol.co.uk
Received 1999 Dec 9; Accepted 1999 Dec 9; Issue date 1999.
Keywords: insurance, genetic testing, Europe, guidelines, breast & ovarian cancer
Copyright © 1999 Hindawi Publishing Corporation.
PMCID: PMC3851117 PMID: 10595272